While FGF2 and leptin are both physiologically relevant in mammary gland development, we hypothesize that higher than normal circulating levels of these adipokines may be contributory to breast cancer in the context of obesity, especially for tumors with FGFR1 amplifications and increased LepR expression. The gene discussed is FGFR1; the disease is breast carcinoma.